GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.

Quick facts

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. portfolio CI brief
• GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies